Shares of Invesque Inc. (TSE:IVQ – Get Rating) dropped 4.9% during mid-day trading on Friday . The company traded as low as C$1.17 and last traded at C$1.17. Approximately 23,700 shares were traded during mid-day trading, an increase of 261% from the average daily volume of 6,569 shares. The stock had previously closed at C$1.23.
Invesque Stock Performance
The company has a current ratio of 0.61, a quick ratio of 0.35 and a debt-to-equity ratio of 309.96. The firm has a market capitalization of C$65.68 million and a PE ratio of -4.62. The firm’s fifty day moving average price is C$1.27 and its 200 day moving average price is C$1.47.
Invesque (TSE:IVQ – Get Rating) last issued its quarterly earnings data on Tuesday, November 8th. The company reported C($0.29) earnings per share for the quarter, missing the consensus estimate of C$0.14 by C($0.43). The company had revenue of C$64.80 million for the quarter. On average, research analysts anticipate that Invesque Inc. will post 0.63 earnings per share for the current year.
Invesque Company Profile
Invesque Inc operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada.
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Invesque Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesque and related companies with MarketBeat.com's FREE daily email newsletter.